Tech Company Financing Transactions

KSQ Therapeutics Funding Round

On 10/3/2017, KSQ Therapeutics raised $76 million in financing from Alexandria Venture Investments, Arch Venture Partners and Flagship Pioneering.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

610 Main St. North 4th Floor
Cambridge, MA 02139
USA

Phone

(617) 674-9150

Website

www.ksqtx.com

Email Address

[email protected]

Overview

KSQ Therapeutics is pioneering High-Confidence Drug Development: a fundamentally new approach to R&D where the majority of the de-risking work is done prior to the generation of therapeutic drug candidates.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Meeker

        

Chief Financial Officer

Douglas Pagán

        

Chief Financial Officer

John Trzupek

        

Chief Scientific Officer

Frank Stegmeier

        

Vice President

Caroline Dugopolski

        

Browse more venture capital transactions:

Prev: 10/3/2017: MetaBrite venture capital transaction
Next: 10/3/2017: Tecovas venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary